The majority of technology vendors––75 percent––believe advanced analytics and AI will be among the top areas of focus for healthcare companies in 2019, according to a survey by Damo Consulting.

As progressive Democrats increasingly push for universal healthcare, known as Medicare for all, support for such a plan is mixed when it comes to paying for it, according to a recent poll from the Kaiser Family Foundation.

The trade group for the U.S.'s top drugmakers spent a record amount—$27.5 million—on lobbying efforts in 2018, according to Bloomberg.

Three executives at Ascension, a nonprofit health system based in St. Louis, are departing from their roles, Ascension President and CEO Anthony Tersigni, EdD, FACHE, said in an announcement.

More industry groups are pushing back against an upcoming deadline for accountable care organizations (ACOs) to apply to the updated Medicare Shared Savings Program.

The Alliance for Artificial Intelligence in Healthcare (AAIH) has officially launched after the board of directors held the organization’s inaugural meeting Jan. 9 in San Francisco.

Medicare payments in 2019 aren’t likely to cover the cost of delivering care for two-thirds of medical practices, according to a survey from the Medical Group Management Association (MGMA).

The average annual cost of managing type 1 diabetes has skyrocketed, with the rising cost of insulin being a main contributor, according to a new issue brief from the Health Care Cost Institute.